Xenon Pharmaceuticals President & CEO Purchased Shares Worth Over $1.1M

Ian Mortimer, President & CEO of Xenon Pharmaceuticals, purchased 30,000 common shares at $37.38 per share, totaling $1,121,400. Mortimer now directly owns 49,923 shares and indirectly owns 14,300 shares.